Cargando…
HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice
People who inject drugs (PWID) and prisoners are considered key populations at risk for human immunodeficiency virus (HIV) and/or Hepatitis C Virus (HCV). In 2016, the Joint United Nations Program on HIV/AIDS (UNAIDS) was implemented to eliminate HIV and AIDS by 2030 and the World Health Organizatio...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100628/ https://www.ncbi.nlm.nih.gov/pubmed/37055763 http://dx.doi.org/10.1186/s12954-023-00774-1 |
_version_ | 1785025318650642432 |
---|---|
author | Stöver, H. Dichtl, A. Schäffer, D. Grabski, M. |
author_facet | Stöver, H. Dichtl, A. Schäffer, D. Grabski, M. |
author_sort | Stöver, H. |
collection | PubMed |
description | People who inject drugs (PWID) and prisoners are considered key populations at risk for human immunodeficiency virus (HIV) and/or Hepatitis C Virus (HCV). In 2016, the Joint United Nations Program on HIV/AIDS (UNAIDS) was implemented to eliminate HIV and AIDS by 2030 and the World Health Organization (WHO) presented the first strategy to eliminate viral hepatitis by 2030 as well. Following the objectives of the WHO and the United Nations, the German Federal Ministry of Health (BMG) presented the first integrated overall strategy for HIV and HCV in 2017. This article discusses the situation of PWID and prisoners in Germany with regard to HIV and HCV five years after the adoption of this strategy, on the basis of available data and against the background of the most recent practice in the field. In order to meet the elimination goals by 2030, Germany will have to improve the situation of PWID and prisoners substantially, mainly through the implementation of evidence-based harm reduction measures as well as the promotion of diagnosis and treatment in prisons and in freedom. |
format | Online Article Text |
id | pubmed-10100628 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101006282023-04-14 HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice Stöver, H. Dichtl, A. Schäffer, D. Grabski, M. Harm Reduct J Review People who inject drugs (PWID) and prisoners are considered key populations at risk for human immunodeficiency virus (HIV) and/or Hepatitis C Virus (HCV). In 2016, the Joint United Nations Program on HIV/AIDS (UNAIDS) was implemented to eliminate HIV and AIDS by 2030 and the World Health Organization (WHO) presented the first strategy to eliminate viral hepatitis by 2030 as well. Following the objectives of the WHO and the United Nations, the German Federal Ministry of Health (BMG) presented the first integrated overall strategy for HIV and HCV in 2017. This article discusses the situation of PWID and prisoners in Germany with regard to HIV and HCV five years after the adoption of this strategy, on the basis of available data and against the background of the most recent practice in the field. In order to meet the elimination goals by 2030, Germany will have to improve the situation of PWID and prisoners substantially, mainly through the implementation of evidence-based harm reduction measures as well as the promotion of diagnosis and treatment in prisons and in freedom. BioMed Central 2023-04-13 /pmc/articles/PMC10100628/ /pubmed/37055763 http://dx.doi.org/10.1186/s12954-023-00774-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Stöver, H. Dichtl, A. Schäffer, D. Grabski, M. HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice |
title | HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice |
title_full | HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice |
title_fullStr | HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice |
title_full_unstemmed | HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice |
title_short | HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice |
title_sort | hiv and hcv among drug users and people living in prisons in germany 2022: who elimination targets as reflected in practice |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100628/ https://www.ncbi.nlm.nih.gov/pubmed/37055763 http://dx.doi.org/10.1186/s12954-023-00774-1 |
work_keys_str_mv | AT stoverh hivandhcvamongdrugusersandpeoplelivinginprisonsingermany2022whoeliminationtargetsasreflectedinpractice AT dichtla hivandhcvamongdrugusersandpeoplelivinginprisonsingermany2022whoeliminationtargetsasreflectedinpractice AT schafferd hivandhcvamongdrugusersandpeoplelivinginprisonsingermany2022whoeliminationtargetsasreflectedinpractice AT grabskim hivandhcvamongdrugusersandpeoplelivinginprisonsingermany2022whoeliminationtargetsasreflectedinpractice |